☰

Joseph Fitzgerald Arboleda-Velasquez - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Littau JL, Velilla L, Hase Y, Villalba-Moreno ND, Hagel C, Drexler D, Osorio Restrepo S, Villegas A, Lopera F, Vargas S, Glatzel M, Krasemann S, Quiroz YT, Arboleda-Velasquez JF, Kalaria R, et al. Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease. Brain Pathology (Zurich, Switzerland). e13097. PMID 35695802 DOI: 10.1111/bpa.13097  0.311
2021 Schoemaker D, Arboleda-Velasquez JF. NOTCH3 SIGNALING AND AGGREGATION AS TARGETS FOR THE TREATMENT OF CADASIL AND OTHER NOTCH3-ASSOCIATED SMALL VESSEL DISEASE. The American Journal of Pathology. PMID 33895122 DOI: 10.1016/j.ajpath.2021.03.015  0.359
2020 Schoemaker D, Zuluaga Y, Viswanathan A, Shrimer M, Torrico-Teave H, Velilla L, Ospina C, Ospina GG, Lopera F, Arboleda-Velasquez JF, Quiroz YT. The INECO Frontal Screening for the Evaluation of Executive Dysfunction in Cerebral Small Vessel Disease: Evidence from Quantitative MRI in a CADASIL Cohort from Colombia. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 32487276 DOI: 10.1017/S1355617720000533  0.353
2020 Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, Garcia G, Villegas A, Sepulveda-Falla D, Villada M, Arboleda-Velasquez JF, Guzmán-Vélez E, Vila-Castelar C, Gordon BA, Schultz SA, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study. The Lancet. Neurology. 19: 513-521. PMID 32470423 DOI: 10.1016/S1474-4422(20)30137-X  0.321
2020 Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, et al. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature Communications. 11: 667. PMID 32015339 DOI: 10.1038/S41467-019-14279-8  0.325
2019 Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nature Medicine. PMID 31686034 DOI: 10.1038/S41591-019-0611-3  0.406
2019 Schoemaker D, Quiroz YT, Torrico-Teave H, Arboleda-Velasquez JF. Clinical and research applications of magnetic resonance imaging in the study of CADASIL. Neuroscience Letters. 698: 173-179. PMID 30634011 DOI: 10.1016/J.Neulet.2019.01.014  0.325
2019 Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Garcia G, L AV, Sepulveda D, Villada M, Arboleda-Velasquez JF, Giraldo M, Guzman-Velez E, Vila-Castelar C, Pardilla-Delgado E, Fuller J, Protas H, et al. Plasma Neurofilament Light Measurements In More Than 2,100 Presenilin-1 E280A Mutation Carriers And Non-Carriers From The World’S Largest Autosomal Dominant Alzheimer’S Disease Kindred Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4861  0.343
2018 Zuluaga-Castaño Y, Montoya-Arenas DA, Velilla L, Ospina C, Arboleda-Velasquez JF, Quiroz YT, Lopera F. Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL. International Journal of Psychological Research. 11: 46-55. PMID 32612778 DOI: 10.21500/20112084.3373  0.431
2018 Rendon J, Zuluaga Y, Velilla L, Ochoa J, Arboleda-Velasquez JF, Budson A, Lopera F, Quiroz YT. Event-Related Potential Correlates of Recognition Memory in Asymptomatic Individuals with CADASIL. Brain Research. PMID 30445028 DOI: 10.1016/J.Brainres.2018.11.016  0.378
2018 Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, et al. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Jama Neurology. PMID 29435558 DOI: 10.1001/Jamaneurol.2017.4907  0.32
2017 Machuca-Parra AI, Bigger-Allen AA, Sanchez AV, Boutabla A, Cardona-Vélez J, Amarnani D, Saint-Geniez M, Siebel CW, Kim LA, D'Amore PA, Arboleda-Velasquez JF. Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL. The Journal of Experimental Medicine. PMID 28698285 DOI: 10.1084/Jem.20161715  0.48
2017 Lam JD, Oh DJ, Wong LL, Amarnani D, Park-Windhol C, Sanchez AV, Cardona-Velez J, McGuone D, Stemmer-Rachamimov AO, Eliott D, Bielenberg DR, van Zyl T, Shen L, Gai X, D'Amore PA, ... ... Arboleda-Velasquez JF, et al. Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis. Diabetes. PMID 28400392 DOI: 10.2337/Db16-1035  0.334
2017 Quiroz YT, Pulsifer M, Chen K, Ramirez D, Londono N, Arboleda-Velasquez J, Martinez J, Chen Y, Guzman-Velez E, Norton D, Langbaum JB, Tariot P, Reiman EM, Lopera F. Cognitive Vulnerabilities In Presenilin-1 E280A Mutation-Carrying Children From The World’S Largest Autosomal-Dominant Alzheimer’S Disease Kindred Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.108  0.36
2016 Primo V, Graham M, Bigger-Allen AA, Chick JM, Ospina C, Quiroz YT, Manent J, Gygi SP, Lopera F, D'Amore PA, Arboleda-Velasquez JF. Blood Biomarkers in a Mouse Model of CADASIL. Brain Research. PMID 27174004 DOI: 10.1016/J.Brainres.2016.05.008  0.423
2015 Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, et al. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. Jama Neurology. PMID 26121081 DOI: 10.1001/Jamaneurol.2015.1099  0.301
2015 Arboleda-Velasquez JF, Valdez CN, Marko CK, D'Amore PA. From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy. Current Diabetes Reports. 15: 573. PMID 25620405 DOI: 10.1007/S11892-014-0573-2  0.309
2014 Valdez CN, Arboleda-Velasquez JF, Amarnani DS, Kim LA, D'Amore PA. Retinal microangiopathy in a mouse model of inducible mural cell loss. The American Journal of Pathology. 184: 2618-26. PMID 25092275 DOI: 10.1016/J.Ajpath.2014.06.011  0.316
2014 Arboleda-Velasquez JF, Primo V, Graham M, James A, Manent J, D'Amore PA. Notch signaling functions in retinal pericyte survival. Investigative Ophthalmology & Visual Science. 55: 5191-9. PMID 25015359 DOI: 10.1167/Iovs.14-14046  0.372
2011 Arboleda-Velasquez JF, Manent J, Lee JH, Tikka S, Ospina C, Vanderburg CR, Frosch MP, Rodríguez-Falcón M, Villen J, Gygi S, Lopera F, Kalimo H, Moskowitz MA, Ayata C, Louvi A, et al. Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proceedings of the National Academy of Sciences of the United States of America. 108: E128-35. PMID 21555590 DOI: 10.1073/Pnas.1101964108  0.623
2008 Arboleda-Velasquez JF, Zhou Z, Shin HK, Louvi A, Kim HH, Savitz SI, Liao JK, Salomone S, Ayata C, Moskowitz MA, Artavanis-Tsakonas S. Linking Notch signaling to ischemic stroke. Proceedings of the National Academy of Sciences of the United States of America. 105: 4856-61. PMID 18347334 DOI: 10.1073/Pnas.0709867105  0.572
2006 Louvi A, Arboleda-Velasquez JF, Artavanis-Tsakonas S. CADASIL: a critical look at a Notch disease. Developmental Neuroscience. 28: 5-12. PMID 16508299 DOI: 10.1159/000090748  0.594
2005 Rampal R, Arboleda-Velasquez JF, Nita-Lazar A, Kosik KS, Haltiwanger RS. Highly conserved O-fucose sites have distinct effects on Notch1 function. The Journal of Biological Chemistry. 280: 32133-40. PMID 15994302 DOI: 10.1074/Jbc.M506104200  0.306
2005 Arboleda-Velasquez JF, Rampal R, Fung E, Darland DC, Liu M, Martinez MC, Donahue CP, Navarro-Gonzalez MF, Libby P, D'Amore PA, Aikawa M, Haltiwanger RS, Kosik KS. CADASIL mutations impair Notch3 glycosylation by Fringe. Human Molecular Genetics. 14: 1631-9. PMID 15857853 DOI: 10.1093/Hmg/Ddi171  0.403
2002 Arboleda-Velasquez JF, Lopera F, Lopez E, Frosch MP, Sepulveda-Falla D, Gutierrez JE, Vargas S, Medina M, Martinez De Arrieta C, Lebo RV, Slaugenhaupt SA, Betensky RA, Villegas A, Arcos-Burgos M, Rivera D, et al. C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology. 59: 277-9. PMID 12136071 DOI: 10.1212/Wnl.59.2.277  0.403
Show low-probability matches.